[go: up one dir, main page]

CL2010000119A1 - Uso de una composicion fitofarmacologica conformada por encelia canescens lam (coronilla de fraile) y excipientes farmaceuticamente aceptables para prevenir o tratar enfermedades neoplasicas, metabolicas o ralacionadas con estrés oxidativo. - Google Patents

Uso de una composicion fitofarmacologica conformada por encelia canescens lam (coronilla de fraile) y excipientes farmaceuticamente aceptables para prevenir o tratar enfermedades neoplasicas, metabolicas o ralacionadas con estrés oxidativo.

Info

Publication number
CL2010000119A1
CL2010000119A1 CL2010000119A CL2010000119A CL2010000119A1 CL 2010000119 A1 CL2010000119 A1 CL 2010000119A1 CL 2010000119 A CL2010000119 A CL 2010000119A CL 2010000119 A CL2010000119 A CL 2010000119A CL 2010000119 A1 CL2010000119 A1 CL 2010000119A1
Authority
CL
Chile
Prior art keywords
phytopharmacological
encelia
friar
neoplasic
canescens
Prior art date
Application number
CL2010000119A
Other languages
English (en)
Inventor
Quevedo M Carlos Quevedo M Edmundo
Quinones Sepulveda Luis
Original Assignee
Naturaleza Y Fe Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naturaleza Y Fe Ltda filed Critical Naturaleza Y Fe Ltda
Priority to CL2010000119A priority Critical patent/CL2010000119A1/es
Publication of CL2010000119A1 publication Critical patent/CL2010000119A1/es
Priority to US13/578,317 priority patent/US8663715B2/en
Priority to PCT/CL2011/000009 priority patent/WO2011097750A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2010000119A 2010-02-10 2010-02-10 Uso de una composicion fitofarmacologica conformada por encelia canescens lam (coronilla de fraile) y excipientes farmaceuticamente aceptables para prevenir o tratar enfermedades neoplasicas, metabolicas o ralacionadas con estrés oxidativo. CL2010000119A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CL2010000119A CL2010000119A1 (es) 2010-02-10 2010-02-10 Uso de una composicion fitofarmacologica conformada por encelia canescens lam (coronilla de fraile) y excipientes farmaceuticamente aceptables para prevenir o tratar enfermedades neoplasicas, metabolicas o ralacionadas con estrés oxidativo.
US13/578,317 US8663715B2 (en) 2010-02-10 2011-01-28 Compositions, products, therapeutic uses and procedures for the production and/or crystallization of extracts of Encelia canescens LAM (coronilla de fraile)
PCT/CL2011/000009 WO2011097750A1 (es) 2010-02-10 2011-01-28 Composiciones, productos, usos terapéuticos y procedimientos de producción y/o cristalización de extractos de encella canescens lam (coronilla de fraile).

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2010000119A CL2010000119A1 (es) 2010-02-10 2010-02-10 Uso de una composicion fitofarmacologica conformada por encelia canescens lam (coronilla de fraile) y excipientes farmaceuticamente aceptables para prevenir o tratar enfermedades neoplasicas, metabolicas o ralacionadas con estrés oxidativo.

Publications (1)

Publication Number Publication Date
CL2010000119A1 true CL2010000119A1 (es) 2010-08-06

Family

ID=44367108

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2010000119A CL2010000119A1 (es) 2010-02-10 2010-02-10 Uso de una composicion fitofarmacologica conformada por encelia canescens lam (coronilla de fraile) y excipientes farmaceuticamente aceptables para prevenir o tratar enfermedades neoplasicas, metabolicas o ralacionadas con estrés oxidativo.

Country Status (3)

Country Link
US (1) US8663715B2 (es)
CL (1) CL2010000119A1 (es)
WO (1) WO2011097750A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US515455A (en) * 1894-02-27 Territory
US20020132021A1 (en) * 1997-04-30 2002-09-19 Ilya Raskin Elicited plant products
JP2003500452A (ja) * 1999-05-27 2003-01-07 アーマディーロ・ファーマシューティカルス・インコーポレーテッド 天然資源から抽出した生物活性物質の医薬製剤
CA2536604A1 (en) * 2002-08-30 2004-03-11 Biopharmacopae Design International Inc. Plant extracts for treatment of angiogenesis and metastasis
US20090004302A1 (en) * 2004-10-15 2009-01-01 Biopharmacopae Design International Inc. Methods and Therapeutic Compositions Comprising Plant Extracts for the Treatment of Cancer
WO2008029136A1 (en) * 2006-09-05 2008-03-13 Ultra Biotech Limited Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof

Also Published As

Publication number Publication date
US8663715B2 (en) 2014-03-04
WO2011097750A1 (es) 2011-08-18
US20130028997A1 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
HUS1900017I1 (hu) Gyûrûs boronsavészter-származékok és terápiás alkalmazásuk
HRP20160551T8 (hr) Kombinirana terapija s pripravcima nanočestica taksana i hedgehog inhibitora
PT2590976E (pt) Derivados da imidazopiridina, seu processo de preparação e sua utilização terapêutica
CL2013000801A1 (es) Composicion farmaceutica que comprende un inhibidor de rankl y una hormona o un derivado de la misma, y uso del inhibidor rankl para preparar dicha composicion
WO2015075558A3 (en) Surgical devices and methods of use thereof
PH12012502129A1 (en) New combination therapy in treatment of oncological and fibrotic diseases
HUE049217T2 (hu) Szövetkárosodás és fibrózis enyhítése LTBP4 elleni ellenanyaggal
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
CL2013000735A1 (es) Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para el tratamiento de enfermedades y condiciones de la piel, tales como rosacea, daño solar cronico, psoriasis, entre otras; kit farmaceutico.
IL220894A (en) Combinations of active substances containing dihydroporone and abamctin
MX2011011109A (es) Formulaciones orales de bendamustina.
CL2013001940A1 (es) Composicion que comprende al menos una fibra soluble y al menos uno seleccionado entre un probiotico vivo, un probiotico inactivo, un medio de cultivo de un probiotico y una combinacion de dos o mas de las tres opciones anteriores; y su uso para aliviar, tratar y/o prevenir sintomas y/o condiciones relacionadas con estres cronico.
BR112013014189A8 (pt) composição farmacêutica, uso de um agente de potencialização e uso de uma composição
EP2687539A4 (en) ANNEXIN V VERSION, ITS MANUFACTURE AND USE
GB2497453B8 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
CL2014003525A1 (es) Composicion farmaceutica que comprende fimasartan, hidroclorotiazida y un aglutinante; procedimiento de preparacion; su uso en el tratamiento de hipertension.
IL220738A0 (en) Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
CO6700840A2 (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia
CL2013003700A1 (es) Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico.
CL2014000623A1 (es) Forma de dosificacion oral que comprende una dispersion del compuesto (2-(1s)-1-(3-etoxi-4-metoxi-fenil)-2-metanosulfonil-etil)-3-oxo-2,3-dihidro-1h-isoindol-4-il)-amida del acido ciclopropanocarboxilico y su uso en el tratamiento y prevencion del cancer, dolor, degeneracion macular, entre otras enfermedades.
CO6541638A2 (es) Combinaciones terapéuticas de teobromina y una antihistamina
BR112013023575A8 (pt) novo derivado de octaidrotienoquinolina, composição farmacêutica compreendendo derivado, e uso destes
AR080933A1 (es) Tratamiento de esclerosis multiple con masitinib
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
MX344189B (es) Formulaciones de mazindol.